Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 20 October 2025 - 21 October 2025

Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Ticker: Beam Therapeutics (NASDAQ: BEAM) globenewswire.com. – Price (Oct 21, 2025): ~$30 per share (about +17% recently) ts2.tech. – Sector: Biotechnology (precision gene editing) globenewswire.com. – Recent News: FDA granted Regenerative Medicine Advanced Therapy (RMAT) and Orphan Drug designations to Beam’s lead programs (BEAM-101 for sickle cell disease and BEAM-302 for alpha-1 antitrypsin deficiency) globenewswire.com stocktitan.net. Early trial data for these programs have been promising. – Analyst Outlook: Consensus is “Moderate Buy” with average 1-year target ~$45–46 marketbeat.com nasdaq.com, implying roughly 70–80% upside. Beam’s stock jumped sharply after the FDA awarded priority designations to its gene-editing therapies. On Oct 20,
21 October 2025
··
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 21.10.2025

{“@context”:”https://schema.org”,”@type”:”LiveBlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-21-10-2025/#live”,”headline”:”Stock Market Today 21.10.2025″,”description”:”Live rolling coverage of technology news: AI, chips, gadgets, software, startups, cybersecurity, telecom, and policy.”,”datePublished”:”2025-10-21T06:00:02-04:00″,”dateModified”:”2025-10-23T06:44:02-04:00″,”coverageStartTime”:”2025-10-21T06:00:02-04:00″,”coverageEndTime”:”2025-10-23T06:44:02-04:00″,”author”:{“@type”:”Organization”,”name”:”TechStock²”},”publisher”:{“@type”:”Organization”,”name”:”TechStock²”,”logo”:{“@type”:”ImageObject”,”url”:”https://ts2.tech/wp-content/uploads/2024/02/cropped-ts2-logo-google.png”}},”inLanguage”:”en-US”,”liveBlogUpdate”:[{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-21-10-2025/#live/u/e4e7152bb08cf7a6″,”headline”:”Weatherford International Q3 Earnings Miss; Profit Drops, Revenue Declines”,”articleBody”:”Weatherford International (WFT) reported Q3 earnings of $81 million, or $1.12 per share, down from $157 million or $2.06 per share a year earlier. Analysts had expected about $1.19 per share in EPS, meaning the report missed estimates. Revenue declined 12.6% to $1.232 billion from $1.409 billion last year. The results underscore ongoing pressure on Weatherfordu0027s activity levels and markets. Overall, EPS and revenue failed to meet expectations.”,”datePublished”:”2025-10-21T19:06:13-04:00″,”dateModified”:”2025-10-21T19:06:13-04:00″,”mainEntityOfPage”:”https://ts2.tech/en/stock-market-today-21-10-2025/#u-e4e7152bb08cf7a6″,”url”:”https://ts2.tech/en/stock-market-today-21-10-2025/#u-e4e7152bb08cf7a6″},{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-21-10-2025/#live/u/186d92a4a72c8603″,”headline”:”Wall Street ends mixed as earnings lift the
21 October 2025
SPRO Stock Skyrockets on Breakthrough Oral Antibiotic Data

SPRO Stock Skyrockets on Breakthrough Oral Antibiotic Data

Stock Performance stockanalysis.com stockanalysis.com Spero’s shares have roughly doubled this year, hitting around $2.29 on Oct 20, 2025. The stock has traded in a broad range ($0.51–$3.22 over 52 weeks) stockanalysis.com. Trading volume is light (hundreds of thousands of shares), and the stock’s beta (~1.46) indicates volatility. In recent days, SPRO has climbed on the back of the Phase 3 data. The 50-day moving average (~$2.03) and 200-day average (~$1.83) (see data marketbeat.com) suggest the trend has turned positive after the spring rally. Year-to-date, SPRO is up ~120%, well above the small-cap biotech average. Recent Developments gsk.com gsk.com At IDWeek
21 October 2025
··
Replimune Stock Rockets 100% on FDA Nod – Analysts Eye Upside

Replimune Stock Rockets 100% on FDA Nod – Analysts Eye Upside

Stock Performance and Recent Rally Replimune’s stock has been extremely volatile in 2025. It soared on Oct. 20 after the FDA acceptance news: shares nearly doubled from about $4.50 to $8.94 that day marketbeat.com. (On Oct 21, REPL was trading around $8.95 reuters.com.) This reversed a mid-year collapse – in July 2025 a disappointing FDA Complete Response Letter caused the stock to collapse ~73% in one day globenewswire.com. Over the past year the 52-week trading range is roughly $2.68 (low) to $17.00 (high) marketbeat.com, reflecting that roller-coaster. Institutional interest remains high: recently hedge funds like TD Asset Management increased their
21 October 2025
·
Beyond Meat (BYND) Stock Skyrockets 50% Amid Meme Mania – Turnaround or Dead Cat Bounce?

Beyond Meat (BYND) Stock Skyrockets 50% Amid Meme Mania – Turnaround or Dead Cat Bounce?

Volatile Stock Action Chart: Beyond Meat (BYND) daily price (1y) via TradingView – after years of decline, BYND plunged to fresh lows in mid-October then briefly spiked amid heavy short covering (note the October jump). fxleaders.com businessinsider.comOver the past week BYND has lived up to its volatile reputation. On Oct. 13–15 the stock collapsed roughly 50–60% as news of the debt-for-equity swap (to repay over $1.1 B of 2027 convertible notes) sank in reuters.com ts2.tech. By Oct. 15 it traded around $0.67 ts2.tech, an all-time low. But the tide quickly turned: in pre-market trading on Oct. 20 the stock jumped ~70% from $0.64
21 October 2025
Netflix Stock Soars: Wall Street Targets $1,500 as Earnings Loom

Netflix Stock Soars: Wall Street Targets $1,500 as Earnings Loom

Macroeconomic Backdrop Investors also consider the broader economy. After a year of volatility, the U.S. Federal Reserve began easing in 2025. By mid-October, the Fed’s benchmark rate was 4.00–4.25% investopedia.com. Economists say Fed officials are trying to gently “take the foot off the brake” on policy to avoid a sharp slowdown investopedia.com. In this environment (lower rates, contained inflation), stocks like Netflix have generally been supported. As one analyst notes, Netflix’s recent gains occurred “in a favorable macroeconomic context, with expectations of monetary easing in the U.S. and relative stability in bond markets” ideal-investisseur.fr. However, rising U.S.–China trade tensions and
21 October 2025
·
Cleveland-Cliffs Stock Rockets on Tariffs and Rare-Earth Push – But Caution Remains

Cleveland-Cliffs Stock Rockets on Tariffs and Rare-Earth Push – But Caution Remains

Stock Price and Recent Movement On Oct. 20, CLF stock surged after-market, reflecting the earnings and strategic announcements. TS2 reports the stock “jumped nearly 20% on October 20, 2025”, reaching an intraday high around $16.50 before settling at about $15.50 ts2.tech. This lifted the share price to a new 52-week high and brought the year-to-date gain to roughly +42% ts2.tech ts2.tech. For comparison, U.S. steel peers like Nucor saw much smaller moves; Nucor’s stock was up ~17% YTD and edged up modestly in late Oct, while CLF jumped sharply ts2.tech. Broad market action was relatively stable on Oct. 20, suggesting CLF’s
21 October 2025
AI Chip Breakthrough Sends GSI Technology (GSIT) Stock Soaring 200% – What Investors Need to Know

AI Chip Breakthrough Sends GSI Technology (GSIT) Stock Soaring 200% – What Investors Need to Know

Cornell Validation Spurs Stock Rally On Oct 20, a Cornell University-led study (MICRO ’25 conference) confirmed that GSI’s Gemini‑I APU can deliver GPU-like AI performance using far less power investing.com economictimes.indiatimes.com. In benchmarks on large retrieval-augmented generation (RAG) workloads, GSI’s chip achieved throughput comparable to an NVIDIA A6000 GPU while using ~98% less energy investing.com economictimes.indiatimes.com. The study also found the APU ran RAG tasks several times faster than standard CPUs (up to 5× speedup or ~80% shorter processing time) investing.com ts2.tech. GSI CEO Lee-Lean Shu hailed the independent validation, saying “Cornell’s independent validation confirms what we’ve long believed –
21 October 2025
··
Cookie Craze & Coffee Buzz: 7 Brew Drive-Thru and Crumbl Cookies Coming to Salisbury

Cookie Craze & Coffee Buzz: 7 Brew Drive-Thru and Crumbl Cookies Coming to Salisbury

Local Expansion: Crumbl Cookies and 7 Brew Arrive in Salisbury Salisbury’s retail scene is getting sweeter (and more caffeinated). Real estate firm SVN | Miller Commercial reports that Crumbl Cookies – famous for its giant pink-box cookies and rotating menu – secured a lease at The Commons shopping center sbybiz.org. The 2,300-square-foot corner space sits beside Ulta and Best Buy. SVN advisor Kelly Jeter led the search, saying Crumbl’s unique concept and “viral flavors” should excite area residents wmdt.com. Build-out has already started, with a target opening in November – just in time for holiday cookie cravings. Meanwhile, 7 Brew, the Arkansas-born drive-thru
21 October 2025
Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple Stock Soars to Record High on iPhone 17 “Supercycle” Buzz – Will the Rally Last?

Apple Stock Hits Record High on iPhone Buzz Apple’s share price surged to a record peak on Oct. 20 as investors piled in on upbeat news about the iPhone 17 launch. The stock jumped nearly 4%, closing around $262 – a new all-time high that eclipses the previous peak of $259 set last yearappleinsider.com. In intraday trading, AAPL reached as high as ~$264, briefly valuing the company at about $3.9 trillion, the highest ever and putting Apple within striking distance of the unprecedented $4 trillion marktradingnews.comtradingnews.com. This rally marked a sharp sentiment shift for Apple, which until recently had been lagging behind
20 October 2025
·
Beam Therapeutics Stock Soars on Gene-Editing Buzz – Analysts Project Big Upside

Beam Therapeutics Stock Soars on Gene-Editing Buzz – Analysts Project Big Upside

Beam Stock Rallies on Technical Breakout Beam Therapeutics’ stock surged on Monday, Oct. 20, extending a strong upward streak. By mid-afternoon the share price hit $30.35, up 16.8% for the dayfinviz.com. This marked BEAM’s highest price since early 2024 and a dramatic rebound from its summer lows. Traders point to a bullish “golden cross” pattern on Beam’s chart – the stock’s 50-day moving average recently rose above its 200-day averagefinviz.com, a technical signal often seen as confirmation of a positive trend reversal. Zacks noted that BEAM had rallied ~6.8% over the prior four weeks leading into this golden-cross eventfinviz.com, helping
20 October 2025
·
Celcuity Stock Skyrockets 40% to Record High on ‘Practice-Changing’ Cancer Trial Results

Celcuity Stock Skyrockets 40% to Record High on ‘Practice-Changing’ Cancer Trial Results

Stock Soars on Positive Trial News Celcuity’s stock price skyrocketed on October 20, 2025 after the Minneapolis-based biotech reported game-changing clinical trial results. Shares jumped from around $52 to as high as $78–$81 intradaymarketbeat.com, an approximately 40–50% single-day leap, before settling near a record high close. This surge marked a new 52-week high of $81.56marketbeat.com and lifted Celcuity’s market capitalization above $2.2 billioninvesting.com. The stunning rally came on unusually heavy trading volume as investors rushed to buy shares, propelled by news from a major cancer conference. The immediate catalyst was Celcuity’s Phase 3 VIKTORIA-1 trial data presented over the weekend at
20 October 2025
·
Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Salesforce Stock Surges After $60B AI Bombshell – Here’s What’s Next (Oct 20, 2025)

Stock Performance: Bumpy Ride Followed by AI-Fueled Bounce After a bumpy few months, Salesforce stock has shown signs of stabilizing in October. Shares hit a multi-month low of $235.69 on Oct. 1 amid broader market weakness and lingering post-earnings worriests2.tech. That slump — roughly a 7% drop in September — was fueled by soft guidance from management on future sales, which tempered expectations despite strong last-quarter resultsts2.tech. Early in October, an alarming (though ultimately indirect) security scare added to jitters: a hacker group claimed to have stolen data from Salesforce clients’ databases, sparking headlines about a potential breachts2.tech. Salesforce assured
20 October 2025
···
GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

GRAIL Stock Rockets on Samsung Mega-Deal and Cancer Test Breakthrough

Samsung Alliance Triggers Record Rally GRAIL’s stock price exploded after the company announced a strategic alliance with Samsung on October 16. Under the deal, Samsung C&T will invest $110 million in GRAIL and become the exclusive distributor of the Galleri multi-cancer blood test in South Korea, with rights to expand into Japan and Singaporets2.tech. Samsung Electronics is also participating and plans to explore AI and health-data collaborations with GRAILts2.tech. This marks a major vote of confidence from one of Asia’s largest conglomerates. The partnership is expected to close by early 2026 (pending conditions) and gives GRAIL a powerful commercialization partner in
20 October 2025
··
TKMS Stock Skyrockets in Debut, Doubling Analyst Forecasts Amid Defense Boom

TKMS Stock Skyrockets in Debut, Doubling Analyst Forecasts Amid Defense Boom

Frankfurt, Oct. 20, 2025 – Shares of Thyssenkrupp Marine Systems (TKMS) – the warship-building arm of Thyssenkrupp – made a splashy entrance on the Frankfurt Stock Exchange today. The newly listed stock surged far above initial expectations as investors clamored for a piece of Europe’s booming defense sectorreuters.comdailysabah.com. Key Facts: TKMS Stock Soars in Market Debut Investors sent TKMS’s share price skyrocketing in its first trading session. The stock launched at €60 per share on Monday morning and quickly surged amid heavy buying interestdailysabah.com. Within hours it nearly doubled, hitting an intraday high of €107, before pulling back to close
20 October 2025
··
IonQ’s 2025 Quantum Leap: Surging Stock, Bold Ambitions & How It Compares to Rigetti and D-Wave

IonQ Stock’s Quantum Leap: Soaring 700% in a Year, $2 B Cash Boost & Bold Plans – Bubble or Breakthrough?

Stock Price & Intraday Movement (Oct 20, 2025) IonQ celebrated its public listing on the NYSE as a pure-play quantum computing company. IonQ’s stock seesawed on Monday amid continued volatility. After opening near $65, IONQ shares briefly spiked to about $65.50 before reversing and dipping as low as $58.80 intradaystockanalysis.com. By afternoon, the stock stabilized around $62.5, essentially flat (-0.6%) versus last week’s closestockanalysis.com. This breather comes on the heels of a breathtaking rally: on October 13, IonQ closed at $82.59, capping a single-day +16.9% jumpts2.techts2.tech. That peak marked roughly a +75% gain year-to-date and an astonishing ~700% rise from a year
20 October 2025
·
Alibaba’s 2025 Tech Rally: AI Gold Rush, Stock Soars & What’s Next for 9988.HK

Alibaba Stock Near 4-Year High as AI Ambitions Ignite Rally – Will BABA’s Surge Last?

BABA Stock Soars in 2025: Latest Price and Performance Alibaba Group Holding’s U.S. shares (NYSE: BABA) are trading around $166 as of Monday, October 20, 2025 – hovering near their highest levels in four yearsts2.tech. The stock has roughly doubled in 2025, vastly outperforming broader indices. Year-to-date, BABA is up about 85–97% in valuets2.techbenzinga.com, making it one of the top tech rebound stories of the year. By comparison, the NYSE Composite index has gained only ~12% in 2025benzinga.com. Alibaba’s ADR price hit the mid-$170s earlier this month – territory not seen since 2019 – before a brief pullback. Over the
20 October 2025
···
AT&T Stock Faces Crucial Test: 5G Spectrum Gamble, Fiber Expansion & Earnings Loom

AT&T Stock Faces Crucial Test: 5G Spectrum Gamble, Fiber Expansion & Earnings Loom

Key Facts (as of Oct. 20, 2025): AT&T Stock Price & Recent Performance AT&T’s stock has been stuck in neutral in October, even as broader indexes climb to new highs. Shares closed Friday (Oct. 17) at $26.34nasdaq.com, up slightly from earlier in the week (~$26.07 on Wednesday) but still in the mid-$20s range. This leaves the telecom giant roughly flat month-to-date. By contrast, the S&P 500 and Dow are hovering near record levels after a strong weekts2.tech. Year-to-date, AT&T has not enjoyed a tech-style rally – its stock is up about 15–20% in 2025, trailing the tech-heavy Nasdaq’s ~15% gain
20 October 2025
··
Crypto Stocks Explode as Bitcoin Smashes Records – 5 Hot Picks for October 2025

Marathon Digital Skyrockets on Bitcoin Rebound – Experts Eye Volatility Ahead

MARA Stock Rebounds with Bitcoin’s Recovery Marathon Digital’s stock jumped sharply on Monday, riding a broader crypto market relief rally. By afternoon trade on October 20, MARA shares were up about 8.3% at roughly $21.20investing.com. This surge coincided with Bitcoin climbing back above the $110,000 levelts2.tech, suggesting improved risk appetite after a volatile week. Marathon – one of the largest publicly traded Bitcoin miners – often moves in lockstep with Bitcoin, and its latest spike reflects that tight correlation. Traders pointed to easing macro fears (a U.S. shutdown resolution and hopes of stable interest rates) and renewed optimism around a
20 October 2025
··
Transocean (RIG) Stock Comeback: Insider Buys, New Deals Spark Rally Amid Oil Sector Rebound

Transocean (RIG) Stock Comeback: Insider Buys, New Deals Spark Rally Amid Oil Sector Rebound

Key Facts (as of Oct. 20, 2025) Transocean Rallies on Insider Buy and New Deals Transocean’s stock has staged a modest comeback in mid-October after a slew of positive developments reignited investor interest. On October 16, RIG shares jumped over 5% in a single session as the market cheered news of insider buying, fresh contracts, and proactive debt refinancings ts2.tech. The rally was spurred in part by Frederik Wilhelm Mohn – a Transocean board member and scion of a prominent Norwegian oil family – accumulating 4 million shares (about $12.2 million worth) in the recent equity offering ts2.tech. Such a purchase
20 October 2025
··
1 … 1,104 1,105 1,106 1,107 1,108 … 1,171

Stock Market Today

Ucore Rare Metals stock price jumps as ‘Project Vault’ keeps rare earths on traders’ screens

Ucore Rare Metals stock price jumps as ‘Project Vault’ keeps rare earths on traders’ screens

7 February 2026
Ucore Rare Metals shares jumped 14.7% to C$7.97 on Toronto’s TSX Venture Exchange Friday, rebounding after a steep drop as investors responded to U.S. critical-minerals policy moves. The U.S. Export-Import Bank described Project Vault as a $10 billion public-private stockpiling plan. Neodymium prices climbed 1.27% to 997,500 yuan a tonne on Feb. 6. Investors await details on Project Vault’s purchasing plans next week.
Semiconductor stocks surge as AI capex stays high; Nvidia and AMD lead into next week

Semiconductor stocks surge as AI capex stays high; Nvidia and AMD lead into next week

7 February 2026
The Philadelphia Semiconductor Index jumped 5.7% to 8,048.6 on Friday, with Nvidia up 7.87% and AMD rising 8.28%. The surge followed new forecasts showing global chip sales could hit $1 trillion in 2026. Amazon expects a 50% increase in capital spending this year, fueling demand for chips. The Dow Jones crossed 50,000, helped by gains in chipmakers.
Oil stocks jump on Iran risk lift for crude — what to watch before Monday

Oil stocks jump on Iran risk lift for crude — what to watch before Monday

7 February 2026
U.S. oil stocks surged Friday as crude prices rose on renewed Middle East tensions. Exxon Mobil gained 2.0%, ConocoPhillips 2.5%, and Occidental Petroleum 2.7%. Refiners rallied after a national union deal eased strike risk, though BP’s Whiting plant faces a local dispute. Brent settled at $68.05 a barrel, up 0.74%.
Go toTop